Lineage Cell Therapeutics Inc (FRA:BT3)
€ 1.036 (0%) Market Cap: 256.13 Mil Enterprise Value: 210.33 Mil PE Ratio: 0 PB Ratio: 5.42 GF Score: 78/100

Lineage Cell Therapeutics Inc (FRA:BT3) Transcripts

  • 1